Zobrazeno 1 - 10
of 966
pro vyhledávání: '"C, Stahle"'
Publikováno v:
Biochemistry. 47:2884-2892
This investigation examined the molecular mechanisms that enable the alphaIIbbeta3 integrin to bind efficiently, tightly, and selectively to echistatin, an RGD disintegrin. We used surface plasmon resonance spectroscopy to measure the rate, extent, a
Publikováno v:
Journal of Thrombosis and Haemostasis. 5:542-550
Background Drugs that block platelet-platelet and platelet-fibrin interactions via the alpha(IIb)beta(3) (glycoprotein IIb/IIIa) receptor are used daily in patients undergoing percutaneous coronary interventions. Along with expected increases in spon
Publikováno v:
Thrombosis and Haemostasis. 87:910-917
SummaryA biophysical approach tested the hypothesis that tirofiban, like eptifibatide, perturbs GpIIb/IIIa structure. Tirofiban bound tightly to platelet GpIIb/IIIa (EC50 ∼ 24 nmol/L) and effectively inhibited platelet aggregation (IC50 ∼ 37 nmol
Autor:
Douglas S. Lyles, W.G Jerome, V Del Gaizo, Margie O. McKenzie, M Adams, T Lasher, Mary C. Stahle, Roy R. Hantgan
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1540(1):82-95
The platelet integrin αIIbβ3 exhibits bidirectional signaling, in that intracellular messengers enable adhesive macromolecules to bind to its ectodomain, while ligation promotes the association of cytoskeletal proteins with its cytoplasmic domains.
Autor:
Meulewaeter, Evelyn1 (AUTHOR), Eylenbosch, Anke1 (AUTHOR), Verhaeghe, Evelien1 (AUTHOR), Soenen, Rani1 (AUTHOR), Lambert, Jo1 (AUTHOR) Jo.Lambert@uzgent.be
Publikováno v:
Dermatology & Therapy. Oct2024, Vol. 14 Issue 10, p2889-2903. 15p.
Autor:
Lebwohl, Mark G.1 (AUTHOR) lebwohl@aol.com, Armstrong, April W.2 (AUTHOR), Alexis, Andrew F.3 (AUTHOR), Lain, Edward L.4 (AUTHOR), Jacobson, Abby A.5 (AUTHOR)
Publikováno v:
Dermatology & Therapy. Oct2024, Vol. 14 Issue 10, p2709-2726. 18p.
Autor:
GH Mickisch, I Aksentijevich, PV Schoenlein, LJ Goldstein, H Galski, C Stahle, DH Sachs, I Pastan, MM Gottesman
Publikováno v:
Blood. 79:1087-1093
Many human cancers that are initially responsive to chemotherapy eventually fail to respond to treatment. For some drugs, dose escalation that may be required for a cure cannot be achieved because sensitive tissues such as bone marrow (BM) limit cyto
Autor:
Mary C. Stahle, Roy R. Hantgan
Publikováno v:
Biochemistry. 48(35)
This investigation addressed the paradox that disintegrins and small RGD-ligands readily bind to the resting alphaIIbbeta3 integrin, while macromolecules with similar integrin recognition motifs require an activated, or primed, receptor. Three struct
Autor:
Mary C. Stahle, Clinton Orebaugh, Jillian G. Rouse, Luke Burnett, Roy R. Hantgan, Mark Van Dyke
Publikováno v:
The FASEB Journal. 23
Autor:
Mary C. Stahle, Mary Ann McLane, David A. Horita, Sergiy Yakovlev, Mattia Rocco, John H. Connor, Leonid Medved, Roy R. Hantgan
Publikováno v:
Protein science : a publication of the Protein Society. 15(8)
This study tested the hypothesis that high-affinity binding of macromolecular ligands to the alphaIIbbeta3 integrin is tightly coupled to binding-site remodeling, an induced-fit process that shifts a conformational equilibrium from a resting toward a